PEMETREXED

PEMETREXED was reported 39095 times

PEMETREXED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EROSIVE PUSTULAR DERMATOSIS 20 0.4000
1 PSEUDOCELLULITIS 69 0.3224
2 SCLEROEDEMA 12 0.2069
3 HETEROPLASIA 8 0.2051
4 BRAIN RADIATION NECROSIS 13 0.1757
5 LUNG ADENOCARCINOMA RECURRENT 15 0.1456
6 FLAGELLATE DERMATITIS 9 0.1385
7 BRAF V600E MUTATION POSITIVE 8 0.1311
8 MENINGITIS NONINFECTIVE 8 0.1270
9 MALIGNANT NEOPLASM OLIGOPROGRESSION 25 0.1256
10 AUTOIMMUNE LUNG DISEASE 14 0.1186
11 EGFR GENE MUTATION 44 0.1176
12 IMMUNE-MEDIATED OESOPHAGITIS 8 0.1111
13 SCLERODERMA-LIKE REACTION 17 0.1076
14 LUNG ADENOCARCINOMA STAGE IV 38 0.0997
15 ENDOCRINE TOXICITY 9 0.0882
16 BILIRUBINURIA 9 0.0857
17 IMMUNE-MEDIATED LUNG DISEASE 156 0.0855
18 HYPERPHOSPHATURIA 10 0.0855
19 K-RAS GENE MUTATION 9 0.0849
20 TRACHEAL FISTULA 13 0.0844
21 NON-SMALL CELL LUNG CANCER METASTATIC 70 0.0796
22 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 17 0.0746
23 NON-SMALL CELL LUNG CANCER 357 0.0745
24 IMMUNE-MEDIATED DERMATITIS 75 0.0744
25 LEUKAEMIA CUTIS 11 0.0714
26 MALIGNANT TRANSFORMATION 32 0.0713
27 NON-SMALL CELL LUNG CANCER RECURRENT 19 0.0671
28 NECROTIC LYMPHADENOPATHY 8 0.0667
29 ACQUIRED GENE MUTATION 86 0.0656
30 IMMUNE-MEDIATED NEUROPATHY 10 0.0645
31 IMMUNE-MEDIATED ARTHRITIS 24 0.0630
32 IMMUNE-MEDIATED GASTRITIS 12 0.0625
33 DRUG RESISTANCE MUTATION 11 0.0618
34 MICROVASCULAR CORONARY ARTERY DISEASE 12 0.0558
35 AUTOIMMUNE NEPHRITIS 12 0.0545
36 AUTOIMMUNE DERMATITIS 8 0.0530
37 IMMUNE-MEDIATED CHOLANGITIS 19 0.0529
38 IMMUNE-MEDIATED HYPOTHYROIDISM 59 0.0523
39 NON-SMALL CELL LUNG CANCER STAGE IV 19 0.0521
40 DERMO-HYPODERMITIS 31 0.0520
41 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 9 0.0495
42 IMMUNE-MEDIATED NEPHRITIS 23 0.0490
43 IMMUNE-MEDIATED HEPATITIS 100 0.0489
44 TUMOUR PSEUDOPROGRESSION 51 0.0466
45 HYPERCREATININAEMIA 23 0.0457
46 LUNG ADENOCARCINOMA 137 0.0455
47 IMMUNE-MEDIATED ENTEROCOLITIS 167 0.0454
48 PLEURAL MESOTHELIOMA MALIGNANT 14 0.0453
49 PLEURAL ADHESION 9 0.0450
50 CANCER FATIGUE 10 0.0420
51 TUMOUR ASSOCIATED FEVER 17 0.0416
52 IMMUNE-MEDIATED RENAL DISORDER 17 0.0411
53 FEBRILE BONE MARROW APLASIA 174 0.0409
54 GLUCOCORTICOID DEFICIENCY 17 0.0402
55 TOXIC ERYTHEMA OF CHEMOTHERAPY 10 0.0386
56 AUTOIMMUNE HYPOTHYROIDISM 9 0.0378
57 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 30 0.0376
58 XERODERMA 10 0.0375
59 RADIATION NECROSIS 21 0.0366
60 ACUTE INTERSTITIAL PNEUMONITIS 19 0.0364
61 NEONATAL RESPIRATORY DEPRESSION 12 0.0361
62 METASTASES TO ADRENALS 33 0.0358
63 IMMUNE-MEDIATED HYPOPHYSITIS 16 0.0355
64 LUNG ADENOCARCINOMA METASTATIC 8 0.0343
65 CELLULITE 11 0.0337
66 LICHENOID KERATOSIS 77 0.0337
67 SUPERIOR VENA CAVA SYNDROME 20 0.0331
68 SPINAL CORD ABSCESS 9 0.0330
69 PRIMARY ADRENAL INSUFFICIENCY 10 0.0328
70 LYMPHOCYTIC HYPOPHYSITIS 9 0.0326
71 IMMUNE-MEDIATED THYROIDITIS 16 0.0324
72 MYASTHENIC SYNDROME 25 0.0323
73 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 57 0.0320
74 METASTASES TO THE MEDIASTINUM 13 0.0316
75 IMMUNE-MEDIATED HYPERTHYROIDISM 8 0.0315
76 IMMUNE-MEDIATED PANCREATITIS 12 0.0315
77 SECONDARY HYPERTENSION 9 0.0315
78 HYPOPHYSITIS 63 0.0313
79 AUTOIMMUNE COLITIS 20 0.0310
80 LYMPHANGIOSIS CARCINOMATOSA 32 0.0307
81 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 38 0.0305
82 NEPHRITIS 100 0.0299
83 PEPTIC ULCER PERFORATION 9 0.0298
84 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 26 0.0296
85 BRONCHOPLEURAL FISTULA 11 0.0293
86 BRONCHOSTENOSIS 16 0.0293
87 AORTITIS 20 0.0292
88 OCULAR MYASTHENIA 10 0.0292
89 VISCERAL LEISHMANIASIS 21 0.0291
90 METASTASES TO PLEURA 30 0.0286
91 IMMUNE-MEDIATED HEPATIC DISORDER 55 0.0282
92 MALIGNANT PLEURAL EFFUSION 47 0.0278
93 HYPERAMYLASAEMIA 15 0.0275
94 SYSTEMIC SCLERODERMA 20 0.0275
95 GENE MUTATION 53 0.0268
96 THROMBOPHLEBITIS MIGRANS 9 0.0265
97 RADIATION OESOPHAGITIS 10 0.0262
98 HAEMATOTOXICITY 248 0.0261
99 IMMUNE-MEDIATED MYOCARDITIS 42 0.0260
100 THERAPY PARTIAL RESPONDER 405 0.0259
101 PARONYCHIA 113 0.0257
102 SKIN TOXICITY 145 0.0256
103 OESOPHAGEAL FISTULA 8 0.0252
104 PARANEOPLASTIC SYNDROME 17 0.0251
105 METASTASES TO MENINGES 56 0.0246
106 IMMUNE-MEDIATED ENCEPHALITIS 13 0.0246
107 RADIATION PNEUMONITIS 51 0.0238
108 NEUTROPENIC COLITIS 46 0.0222
109 GRANULOCYTE COUNT INCREASED 9 0.0222
110 IMMUNE-MEDIATED ADVERSE REACTION 33 0.0215
111 BLOOD PHOSPHORUS ABNORMAL 10 0.0212
112 HEPATIC CYTOLYSIS 267 0.0209
113 SECONDARY ADRENOCORTICAL INSUFFICIENCY 31 0.0205
114 HYPOPITUITARISM 35 0.0201
115 RENAL TUBULAR NECROSIS 197 0.0201
116 PNEUMONITIS 545 0.0200
117 NECROTISING MYOSITIS 17 0.0196
118 PULMONARY ARTERY THROMBOSIS 15 0.0195
119 BICYTOPENIA 38 0.0194
120 CANDIDA TEST POSITIVE 8 0.0191
121 STASIS DERMATITIS 13 0.0190
122 TUBULOINTERSTITIAL NEPHRITIS 356 0.0190
123 SUPERINFECTION BACTERIAL 15 0.0189
124 TRACHEO-OESOPHAGEAL FISTULA 12 0.0188
125 HYPERGAMMAGLOBULINAEMIA 9 0.0186
126 RENAL TUBULAR DISORDER 51 0.0181
127 PANCYTOPENIA 1010 0.0181
128 RADIOTHERAPY 34 0.0178
129 HYPERSENSITIVITY PNEUMONITIS 20 0.0176
130 EPIDERMOLYSIS 8 0.0174
131 EXTREMITY NECROSIS 30 0.0172
132 ENTEROCOCCUS TEST POSITIVE 11 0.0170
133 MALIGNANT NEOPLASM PROGRESSION 1726 0.0168
134 METASTASES TO CENTRAL NERVOUS SYSTEM 217 0.0168
135 OTOTOXICITY 31 0.0167
136 SUPERFICIAL VEIN THROMBOSIS 14 0.0166
137 MYELOPROLIFERATIVE NEOPLASM 11 0.0166
138 GASTROINTESTINAL TOXICITY 79 0.0164
139 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 18 0.0164
140 HYPERTRANSAMINASAEMIA 113 0.0162
141 ADENOCARCINOMA 36 0.0160
142 ANAL ULCER 13 0.0159
143 FULMINANT TYPE 1 DIABETES MELLITUS 16 0.0155
144 OCULAR TOXICITY 17 0.0154
145 HEART FAILURE WITH REDUCED EJECTION FRACTION 8 0.0150
146 ERYSIPELAS 75 0.0149
147 INTESTINAL PSEUDO-OBSTRUCTION 13 0.0148
148 AORTIC THROMBOSIS 17 0.0147
149 OESOPHAGITIS ULCERATIVE 10 0.0146
150 LYMPHADENOPATHY MEDIASTINAL 28 0.0146
151 METASTASES TO KIDNEY 8 0.0145
152 SYSTEMIC INFECTION 24 0.0145
153 SQUAMOUS CELL CARCINOMA OF LUNG 11 0.0143
154 OVERLAP SYNDROME 10 0.0143
155 DUODENAL PERFORATION 14 0.0143
156 TUMOUR NECROSIS 15 0.0142
157 RENAL TUBULAR INJURY 17 0.0140
158 PULMONARY TOXICITY 99 0.0140
159 URINARY TRACT INFECTION ENTEROCOCCAL 13 0.0139
160 SMALL CELL LUNG CANCER 21 0.0139
161 NEPHROPATHY TOXIC 155 0.0138
162 MEDIASTINITIS 8 0.0138
163 DOSE CALCULATION ERROR 8 0.0137
164 LUNG CANCER METASTATIC 39 0.0135
165 DERMATITIS ACNEIFORM 82 0.0135
166 NEUTROPENIC SEPSIS 96 0.0134
167 ADRENAL ADENOMA 8 0.0134
168 HYDROTHORAX 11 0.0133
169 KIDNEY FIBROSIS 23 0.0132
170 OESOPHAGEAL PERFORATION 11 0.0132
171 HYPERTHYROIDISM 187 0.0129
172 FEBRILE INFECTION 15 0.0127
173 CORNEAL PERFORATION 8 0.0127
174 BONE MARROW TOXICITY 15 0.0127
175 FOETAL EXPOSURE TIMING UNSPECIFIED 9 0.0125
176 EMBOLISM VENOUS 38 0.0125
177 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 94 0.0125
178 EMBOLISM ARTERIAL 15 0.0125
179 MYELOSUPPRESSION 445 0.0123
180 MUCOSAL INFLAMMATION 322 0.0123
181 APLASIA 24 0.0122
182 PALMAR ERYTHEMA 14 0.0121
183 FEBRILE NEUTROPENIA 799 0.0120
184 CARCINOEMBRYONIC ANTIGEN INCREASED 23 0.0119
185 DRUG RESISTANCE 299 0.0116
186 PERFORMANCE STATUS DECREASED 54 0.0116
187 BRONCHIAL CARCINOMA 9 0.0114
188 MIXED LIVER INJURY 34 0.0113
189 GOUTY ARTHRITIS 9 0.0113
190 MYOCARDITIS 127 0.0111
191 ADMINISTRATION SITE EXTRAVASATION 11 0.0110
192 LEUKOCYTURIA 9 0.0109
193 NEPHROSCLEROSIS 12 0.0108
194 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 15 0.0107
195 MYOCARDIAL INJURY 12 0.0107
196 ADRENAL INSUFFICIENCY 129 0.0106
197 HYPOALBUMINAEMIA 81 0.0104
198 LUNG CONSOLIDATION 29 0.0104
199 IMMUNE THROMBOCYTOPENIA 47 0.0103
200 CANCER PAIN 26 0.0102
201 HYPERPLASIA 9 0.0100
202 EROSIVE DUODENITIS 8 0.0100
203 MULTIPLE-DRUG RESISTANCE 31 0.0100
204 OESOPHAGITIS 109 0.0100
205 AUTOIMMUNE HAEMOLYTIC ANAEMIA 34 0.0099
206 ADRENAL DISORDER 19 0.0099
207 MONOCYTE COUNT DECREASED 12 0.0098
208 HYPOTHYROIDISM 312 0.0098
209 DISEASE PROGRESSION 1147 0.0097
210 PULMONARY SEPSIS 14 0.0096
211 HEPATOTOXICITY 214 0.0096
212 NEOPLASM PROGRESSION 333 0.0096
213 NEPHROGENIC DIABETES INSIPIDUS 11 0.0095
214 INTERSTITIAL LUNG DISEASE 451 0.0093
215 PERIPHERAL ISCHAEMIA 38 0.0093
216 ADRENOCORTICAL INSUFFICIENCY ACUTE 18 0.0092
217 TYPE 1 DIABETES MELLITUS 55 0.0091
218 HILAR LYMPHADENOPATHY 8 0.0091
219 CLOSTRIDIUM COLITIS 11 0.0091
220 SMALL INTESTINAL PERFORATION 17 0.0091
221 ENTERITIS 58 0.0091
222 PHARYNGEAL INFLAMMATION 11 0.0090
223 VANISHING BILE DUCT SYNDROME 10 0.0090
224 LARGE INTESTINE INFECTION 11 0.0089
225 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 10 0.0089
226 THROMBOCYTOPENIA 997 0.0089
227 PLEURAL FIBROSIS 9 0.0088
228 PERIPHERAL SENSORIMOTOR NEUROPATHY 11 0.0088
229 COLITIS 330 0.0087
230 MALLORY-WEISS SYNDROME 11 0.0087
231 CHOLANGITIS 53 0.0085
232 RESTRICTIVE PULMONARY DISEASE 10 0.0085
233 METASTASES TO LUNG 97 0.0084
234 LUNG OPACITY 22 0.0083
235 BONE MARROW FAILURE 169 0.0083
236 LISTERIOSIS 9 0.0081
237 ALANINE AMINOTRANSFERASE ABNORMAL 17 0.0081
238 PROTEINURIA 152 0.0080
239 LEUKOPENIA 398 0.0079
240 SUBCLAVIAN VEIN THROMBOSIS 9 0.0079
241 NEUTROPENIA 1071 0.0079
242 PRERENAL FAILURE 11 0.0078
243 AUTOIMMUNE HEPATITIS 54 0.0078
244 ARTERIAL THROMBOSIS 15 0.0078
245 DACRYOSTENOSIS ACQUIRED 10 0.0077
246 TRANSITIONAL CELL CARCINOMA 10 0.0077
247 METASTASES TO LIVER 134 0.0076
248 ENTEROCOLITIS 44 0.0076
249 IMMUNE-MEDIATED MYOSITIS 21 0.0076
250 POLYARTHRITIS 40 0.0076
251 PNEUMOPERITONEUM 14 0.0076
252 METASTASES TO LYMPH NODES 51 0.0075
253 HEPATITIS 193 0.0075
254 METASTASES TO PERITONEUM 19 0.0075
255 DUODENITIS 23 0.0075
256 BLOOD CHLORIDE DECREASED 19 0.0074
257 THYROIDITIS 22 0.0073
258 HYPOMAGNESAEMIA 101 0.0072
259 ESCHERICHIA BACTERAEMIA 17 0.0072
260 ASPARTATE AMINOTRANSFERASE ABNORMAL 11 0.0072
261 VASCULAR PURPURA 10 0.0072
262 RASH MACULO-PAPULAR 159 0.0071
263 METASTASIS 51 0.0071
264 STAPHYLOCOCCUS TEST POSITIVE 15 0.0071
265 TOXIC EPIDERMAL NECROLYSIS 108 0.0071
266 DIABETES INSIPIDUS 17 0.0071
267 ANAEMIA MACROCYTIC 15 0.0070
268 METASTASES TO BONE 115 0.0070
269 EMBOLISM 58 0.0070
270 LARGE INTESTINE PERFORATION 48 0.0069
271 DERMATITIS EXFOLIATIVE GENERALISED 24 0.0069
272 ANAEMIA 1313 0.0069
273 INFLAMMATORY MARKER INCREASED 34 0.0069
274 PERIPHERAL SENSORY NEUROPATHY 40 0.0068
275 TUMOUR PAIN 9 0.0068
276 ISCHAEMIA 31 0.0067
277 CYTOPENIA 82 0.0067
278 SUSPECTED OFF LABEL USE 30 0.0066
279 NON-CARDIAC CHEST PAIN 21 0.0066
280 VENA CAVA THROMBOSIS 11 0.0066
281 PANNICULITIS 16 0.0066
282 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 63 0.0066
283 EMPYEMA 13 0.0065
284 HYPERPHOSPHATAEMIA 14 0.0065
285 DERMATITIS BULLOUS 47 0.0065
286 PERIPHERAL MOTOR NEUROPATHY 9 0.0064
287 CULTURE URINE POSITIVE 9 0.0064
288 VENOUS THROMBOSIS 25 0.0064
289 PERIORBITAL OEDEMA 33 0.0063
290 HYPOCALCAEMIA 119 0.0063
291 HAEMOPTYSIS 175 0.0063
292 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 9 0.0063
293 PERICARDIAL EFFUSION 144 0.0062
294 POLYMYOSITIS 11 0.0062
295 MUTISM 9 0.0062
296 HEPATITIS TOXIC 16 0.0061
297 METASTATIC NEOPLASM 26 0.0060
298 PLEURAL EFFUSION 364 0.0060
299 HEPATITIS CHOLESTATIC 36 0.0060
300 DUODENAL ULCER HAEMORRHAGE 17 0.0059
301 KERATITIS 18 0.0059
302 NEOPLASM RECURRENCE 20 0.0059
303 CARDIAC TAMPONADE 28 0.0059
304 BRAIN NATRIURETIC PEPTIDE INCREASED 18 0.0058
305 NEUTROPHIL COUNT DECREASED 237 0.0058
306 GASTROINTESTINAL PERFORATION 24 0.0058
307 TOXIC SKIN ERUPTION 58 0.0058
308 SPLENIC INFARCTION 10 0.0057
309 HEPATITIS ACUTE 37 0.0057
310 ENCEPHALITIS 39 0.0056
311 DYSAESTHESIA 17 0.0055
312 CYTOKINE RELEASE SYNDROME 111 0.0055
313 ACUTE KIDNEY INJURY 840 0.0055
314 ATELECTASIS 53 0.0055
315 PNEUMOCYSTIS JIROVECII PNEUMONIA 55 0.0055
316 RHEUMATOID NODULE 15 0.0054
317 NORMOCYTIC ANAEMIA 8 0.0054
318 CAPILLARY LEAK SYNDROME 11 0.0053
319 INTERVERTEBRAL DISCITIS 10 0.0053
320 PNEUMOTHORAX 84 0.0053
321 BLOOD THYROID STIMULATING HORMONE DECREASED 24 0.0053
322 HYPOPROTEINAEMIA 10 0.0053
323 GRANULOCYTOPENIA 30 0.0053
324 MANTLE CELL LYMPHOMA 8 0.0053
325 HYPOKALAEMIA 242 0.0052
326 SCLERODERMA 19 0.0052
327 SEPTIC SHOCK 227 0.0052
328 CUTANEOUS VASCULITIS 19 0.0052
329 TRAUMATIC LUNG INJURY 10 0.0052
330 HAEMOTHORAX 15 0.0052
331 GENERAL PHYSICAL HEALTH DETERIORATION 589 0.0051
332 FUNGAEMIA 8 0.0051
333 JUGULAR VEIN THROMBOSIS 9 0.0051
334 CACHEXIA 26 0.0050
335 CHOLESTASIS 97 0.0050
336 HICCUPS 41 0.0050
337 BONE LESION 18 0.0050
338 NEUTROPHIL COUNT ABNORMAL 14 0.0049
339 INTESTINAL ISCHAEMIA 27 0.0049
340 RESPIRATORY FAILURE 355 0.0049
341 PULMONARY HAEMORRHAGE 38 0.0049
342 TRANSAMINASES INCREASED 108 0.0049
343 IDIOPATHIC PULMONARY FIBROSIS 19 0.0048
344 PULMONARY EMBOLISM 455 0.0048
345 POLYNEUROPATHY 57 0.0048
346 ORAL FUNGAL INFECTION 13 0.0047
347 POLYMYALGIA RHEUMATICA 15 0.0047
348 ERYTHEMA MULTIFORME 44 0.0047
349 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
350 CARDIOTOXICITY 42 0.0047
351 LEFT VENTRICULAR DYSFUNCTION 31 0.0046
352 PYELONEPHRITIS ACUTE 9 0.0046
353 BLOOD ALBUMIN DECREASED 36 0.0045
354 APLASTIC ANAEMIA 23 0.0044
355 HAEMOLYTIC ANAEMIA 39 0.0043
356 INFUSION RELATED REACTION 288 0.0043
357 ISCHAEMIC STROKE 77 0.0043
358 LICHEN PLANUS 10 0.0043
359 HEPATOCELLULAR INJURY 61 0.0043
360 VITILIGO 10 0.0043
361 BLOOD CREATININE INCREASED 278 0.0043
362 HEPATIC FUNCTION ABNORMAL 158 0.0042
363 URINARY TRACT OBSTRUCTION 10 0.0042
364 METASTASES TO SPINE 14 0.0042
365 HEPATIC LESION 18 0.0042
366 AGRANULOCYTOSIS 77 0.0041
367 DYSPNOEA AT REST 12 0.0041
368 ESCHERICHIA SEPSIS 12 0.0041
369 MYOSITIS 37 0.0041
370 RENAL IMPAIRMENT 346 0.0041
371 CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0041
372 CORNEAL DISORDER 9 0.0041
373 STOMATITIS 247 0.0041
374 BLOOD CREATINE INCREASED 18 0.0041
375 CUSHINGOID 13 0.0040
376 LIP OEDEMA 17 0.0040
377 PERSECUTORY DELUSION 10 0.0040
378 INTESTINAL PERFORATION 45 0.0040
379 THROMBOTIC THROMBOCYTOPENIC PURPURA 14 0.0040
380 VASCULITIS 46 0.0039
381 DERMATOMYOSITIS 10 0.0039
382 DRUG-INDUCED LIVER INJURY 123 0.0039
383 DRUG TOLERANCE DECREASED 11 0.0039
384 TUMOUR HAEMORRHAGE 11 0.0039
385 RASH PUSTULAR 28 0.0038
386 ASPARTATE AMINOTRANSFERASE INCREASED 203 0.0038
387 SMALL INTESTINAL OBSTRUCTION 47 0.0038
388 HYPERPYREXIA 16 0.0038
389 LUNG INFILTRATION 33 0.0037
390 HYPONATRAEMIA 209 0.0037
391 TROPONIN INCREASED 28 0.0037
392 ATYPICAL PNEUMONIA 11 0.0037
393 GLOMERULONEPHRITIS 9 0.0037
394 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 15 0.0037
395 DRUG ERUPTION 65 0.0037
396 RENAL FUNCTION TEST ABNORMAL 17 0.0037
397 ORGANISING PNEUMONIA 18 0.0036
398 OPTIC ISCHAEMIC NEUROPATHY 14 0.0036
399 SECOND PRIMARY MALIGNANCY 30 0.0036
400 TACHYARRHYTHMIA 9 0.0036
401 PLATELET COUNT DECREASED 377 0.0035
402 ALANINE AMINOTRANSFERASE INCREASED 216 0.0035
403 HYPOPHOSPHATAEMIA 26 0.0035
404 CEREBRAL ISCHAEMIA 18 0.0035
405 LUMBAR VERTEBRAL FRACTURE 16 0.0035
406 TEARFULNESS 15 0.0035
407 APLASIA PURE RED CELL 12 0.0035
408 PNEUMONIA BACTERIAL 32 0.0035
409 HERPES VIRUS INFECTION 20 0.0035
410 FAECALOMA 19 0.0035
411 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
412 ACUTE RESPIRATORY FAILURE 66 0.0034
413 COLITIS ISCHAEMIC 23 0.0034
414 SUDDEN DEATH 36 0.0034
415 COMPRESSION FRACTURE 18 0.0034
416 C-REACTIVE PROTEIN INCREASED 122 0.0033
417 BRAIN OEDEMA 42 0.0033
418 PHLEBITIS 17 0.0033
419 BONE MARROW DISORDER 10 0.0033
420 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
421 ELECTROLYTE IMBALANCE 38 0.0033
422 TONGUE ULCERATION 11 0.0033
423 AMYLASE INCREASED 12 0.0032
424 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
425 PROCTITIS 9 0.0032
426 GAMMA-GLUTAMYLTRANSFERASE INCREASED 71 0.0032
427 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
428 PURPURA 28 0.0032
429 OESOPHAGEAL STENOSIS 9 0.0032
430 SEPSIS 352 0.0032
431 PNEUMATOSIS INTESTINALIS 9 0.0032
432 ASCITES 92 0.0031
433 MENINGITIS ASEPTIC 14 0.0031
434 MEAN CELL VOLUME INCREASED 8 0.0031
435 GENERAL PHYSICAL CONDITION ABNORMAL 21 0.0031
436 APHTHOUS ULCER 24 0.0031
437 CARDIOGENIC SHOCK 44 0.0031
438 NEPHROTIC SYNDROME 21 0.0031
439 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
440 POLYURIA 25 0.0030
441 LUNG NEOPLASM 13 0.0030
442 THORACIC VERTEBRAL FRACTURE 9 0.0030
443 RESPIRATORY TRACT INFECTION 79 0.0030
444 ODYNOPHAGIA 18 0.0030
445 NEUTROPHILIA 17 0.0030
446 HYPOXIA 105 0.0030
447 PATHOLOGICAL FRACTURE 15 0.0030
448 OSTEONECROSIS OF JAW 73 0.0029
449 MALNUTRITION 33 0.0029
450 ENDOCARDITIS 15 0.0029
451 HYPOVOLAEMIC SHOCK 14 0.0029
452 BLOOD CREATININE ABNORMAL 10 0.0029
453 EMPHYSEMA 29 0.0029
454 PULMONARY FIBROSIS 55 0.0029
455 PLEURISY 17 0.0029
456 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
457 DUODENAL ULCER 20 0.0028
458 JAUNDICE CHOLESTATIC 10 0.0028
459 BLOOD THYROID STIMULATING HORMONE INCREASED 26 0.0028
460 DERMATITIS 59 0.0028
461 MOUTH ULCERATION 59 0.0028
462 SKIN EROSION 9 0.0028
463 DECREASED APPETITE 645 0.0028
464 FLANK PAIN 26 0.0028
465 OESOPHAGEAL CANDIDIASIS 11 0.0028
466 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 195 0.0027
467 PERICARDITIS 46 0.0027
468 ORAL CANDIDIASIS 36 0.0027
469 LIVER INJURY 67 0.0027
470 THROMBOCYTOSIS 10 0.0027
471 RENAL FAILURE 360 0.0027
472 RECURRENT CANCER 11 0.0027
473 PULMONARY MASS 40 0.0027
474 HAEMATOCRIT DECREASED 53 0.0027
475 ARTERIAL OCCLUSIVE DISEASE 21 0.0027
476 BLOOD MAGNESIUM DECREASED 23 0.0027
477 WOUND DEHISCENCE 9 0.0027
478 HEPATIC CYST 9 0.0026
479 AUTOIMMUNE THYROIDITIS 10 0.0026
480 MYOCARDIAL ISCHAEMIA 30 0.0026
481 STAPHYLOCOCCAL SEPSIS 13 0.0026
482 ATRIAL FLUTTER 21 0.0026
483 NEUROLOGICAL SYMPTOM 15 0.0026
484 CHEST X-RAY ABNORMAL 8 0.0026
485 ILEUS 32 0.0026
486 BLOOD UREA INCREASED 43 0.0026
487 SPINAL CORD COMPRESSION 10 0.0026
488 OEDEMA 139 0.0026
489 EPIGASTRIC DISCOMFORT 10 0.0026
490 EMBOLIC STROKE 9 0.0026
491 BLOOD CREATININE DECREASED 8 0.0026
492 SQUAMOUS CELL CARCINOMA 24 0.0025
493 ACUTE RESPIRATORY DISTRESS SYNDROME 45 0.0025
494 SKIN ABRASION 12 0.0025
495 IRIDOCYCLITIS 8 0.0025
496 SARCOIDOSIS 12 0.0025
497 PEMPHIGOID 19 0.0025
498 NECROSIS 14 0.0025
499 FAILURE TO THRIVE 13 0.0025
500 GUILLAIN-BARRE SYNDROME 12 0.0025
501 PNEUMONIA 802 0.0025
502 STEVENS-JOHNSON SYNDROME 55 0.0025
503 BLOOD SODIUM DECREASED 46 0.0024
504 HYPERURICAEMIA 10 0.0024
505 LEUKOCYTOSIS 44 0.0024
506 STRESS CARDIOMYOPATHY 14 0.0024
507 CIRCULATORY COLLAPSE 41 0.0024
508 PANCREATITIS ACUTE 54 0.0024
509 DEEP VEIN THROMBOSIS 156 0.0024
510 PROTEIN TOTAL DECREASED 9 0.0024
511 CARDIOMYOPATHY 35 0.0024
512 WHITE BLOOD CELL COUNT DECREASED 256 0.0024
513 BACTERAEMIA 28 0.0024
514 MYASTHENIA GRAVIS 19 0.0024
515 ADVERSE REACTION 31 0.0023
516 SHOCK HAEMORRHAGIC 19 0.0023
517 EPISTAXIS 174 0.0023
518 ANGIOPATHY 13 0.0023
519 LYMPHOCYTE COUNT DECREASED 41 0.0023
520 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
521 ACUTE MYELOID LEUKAEMIA 36 0.0023
522 GASTROINTESTINAL INFLAMMATION 18 0.0023
523 RASH VESICULAR 11 0.0023
524 DYSPNOEA EXERTIONAL 85 0.0023
525 FACE OEDEMA 38 0.0023
526 GLOSSITIS 8 0.0023
527 BLOOD URIC ACID INCREASED 13 0.0022
528 DIARRHOEA HAEMORRHAGIC 21 0.0022
529 RESPIRATORY DISTRESS 62 0.0022
530 NEUTROPHIL COUNT INCREASED 23 0.0022
531 PANCREATIC DISORDER 11 0.0022
532 NEUROTOXICITY 39 0.0022
533 HYPOVOLAEMIA 13 0.0022
534 PERITONITIS 46 0.0022
535 SKIN REACTION 31 0.0022
536 LIVER FUNCTION TEST INCREASED 47 0.0022
537 SKIN DISORDER 73 0.0022
538 DEHYDRATION 289 0.0022
539 LOCALISED OEDEMA 10 0.0022
540 PLATELET COUNT ABNORMAL 13 0.0021
541 CARDIAC DYSFUNCTION 8 0.0021
542 ARTERIOSCLEROSIS 20 0.0021
543 PERIORBITAL SWELLING 12 0.0021
544 VENTRICULAR EXTRASYSTOLES 22 0.0021
545 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
546 HYPOPHAGIA 54 0.0021
547 OEDEMA PERIPHERAL 257 0.0021
548 ATAXIA 25 0.0021
549 GASTRIC ULCER 40 0.0021
550 CARDIAC FAILURE ACUTE 14 0.0021
551 FOLLICULITIS 22 0.0021
552 DIABETIC KETOACIDOSIS 50 0.0021
553 THYROID DISORDER 32 0.0021
554 ACUTE MYOCARDIAL INFARCTION 61 0.0021
555 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
556 SUBARACHNOID HAEMORRHAGE 21 0.0021
557 ABNORMAL LOSS OF WEIGHT 14 0.0021
558 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
559 GASTRITIS 54 0.0021
560 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 21 0.0020
561 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 47 0.0020
562 HYPERNATRAEMIA 10 0.0020
563 PROTEIN URINE PRESENT 10 0.0020
564 CEREBRAL INFARCTION 49 0.0020
565 HYDRONEPHROSIS 15 0.0020
566 HEPATIC FAILURE 60 0.0020
567 GASTRIC ULCER HAEMORRHAGE 11 0.0020
568 ASPERGILLUS INFECTION 13 0.0020
569 HAEMODYNAMIC INSTABILITY 15 0.0020
570 PYREXIA 678 0.0020
571 FEMORAL NECK FRACTURE 10 0.0019
572 THROMBOTIC MICROANGIOPATHY 19 0.0019
573 MENINGITIS 13 0.0019
574 ANAPHYLACTOID REACTION 8 0.0019
575 SPINAL OSTEOARTHRITIS 17 0.0019
576 AORTIC DISSECTION 8 0.0019
577 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
578 MULTI-ORGAN FAILURE 33 0.0019
579 ATRIAL FIBRILLATION 184 0.0019
580 HAEMOGLOBIN DECREASED 194 0.0019
581 ONYCHOCLASIS 13 0.0019
582 BLOOD BILIRUBIN INCREASED 51 0.0019
583 CONJUNCTIVITIS 35 0.0019
584 CARDIAC FAILURE CHRONIC 8 0.0019
585 LIVER DISORDER 83 0.0019
586 LUNG INFECTION 29 0.0019
587 LYMPHOPENIA 26 0.0018
588 LYMPHADENOPATHY 65 0.0018
589 DIVERTICULUM INTESTINAL 8 0.0018
590 BODY TEMPERATURE DECREASED 18 0.0018
591 ANAPHYLACTIC REACTION 101 0.0018
592 FLUID INTAKE REDUCED 9 0.0018
593 DERMATITIS EXFOLIATIVE 9 0.0018
594 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
595 SKIN INFECTION 20 0.0018
596 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
597 ASTHENIA 667 0.0018
598 STATUS EPILEPTICUS 20 0.0018
599 GINGIVAL BLEEDING 24 0.0018
600 CARDIAC FAILURE 141 0.0018
601 VENTRICULAR TACHYCARDIA 29 0.0018
602 VOMITING 823 0.0017
603 SKIN HYPERPIGMENTATION 15 0.0017
604 TRISMUS 9 0.0017
605 HYPERBILIRUBINAEMIA 18 0.0017
606 LYMPHOEDEMA 12 0.0017
607 MELAENA 38 0.0017
608 PETECHIAE 18 0.0017
609 UPPER GASTROINTESTINAL HAEMORRHAGE 29 0.0017
610 CARPAL TUNNEL SYNDROME 24 0.0017
611 NEPHROPATHY 16 0.0017
612 NEUROPATHY PERIPHERAL 162 0.0017
613 LIPASE INCREASED 13 0.0017
614 COVID-19 PNEUMONIA 20 0.0017
615 ACUTE CORONARY SYNDROME 14 0.0017
616 BLOOD CALCIUM DECREASED 19 0.0017
617 HEMIPLEGIA 14 0.0017
618 DELIRIUM 58 0.0017
619 DIVERTICULITIS 46 0.0017
620 HYPERKALAEMIA 58 0.0017
621 BRONCHIECTASIS 11 0.0016
622 BLOOD DISORDER 13 0.0016
623 DIARRHOEA 1041 0.0016
624 DYSPHAGIA 151 0.0016
625 CYANOSIS 25 0.0016
626 KLEBSIELLA INFECTION 8 0.0016
627 CONSTIPATION 343 0.0016
628 LUNG NEOPLASM MALIGNANT 64 0.0016
629 ORTHOSTATIC HYPOTENSION 27 0.0015
630 DISEASE RECURRENCE 73 0.0015
631 PLATELET COUNT INCREASED 20 0.0015
632 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
633 HEPATOMEGALY 15 0.0015
634 PNEUMONIA ASPIRATION 38 0.0015
635 RASH 662 0.0015
636 RENAL FAILURE ACUTE 64 0.0015
637 EPILEPSY 46 0.0015
638 PROTHROMBIN TIME PROLONGED 9 0.0015
639 RED BLOOD CELL COUNT DECREASED 43 0.0015
640 LUNG DISORDER 73 0.0015
641 CELLULITIS 75 0.0015
642 NAIL DISORDER 13 0.0015
643 HYDROCEPHALUS 8 0.0015
644 ENCEPHALOPATHY 36 0.0015
645 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
646 ACIDOSIS 11 0.0014
647 ANAPHYLACTIC SHOCK 37 0.0014
648 HYPERGLYCAEMIA 52 0.0014
649 HEMIPARESIS 24 0.0014
650 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
651 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
652 BRONCHOSPASM 20 0.0014
653 GASTROINTESTINAL DISORDER 125 0.0014
654 COGNITIVE DISORDER 65 0.0014
655 GINGIVAL PAIN 11 0.0014
656 METABOLIC DISORDER 8 0.0014
657 HYPERCALCAEMIA 17 0.0014
658 EYELID OEDEMA 16 0.0014
659 FAECES SOFT 10 0.0014
660 GENERALISED OEDEMA 17 0.0014
661 GASTROENTERITIS 20 0.0014
662 GROIN PAIN 12 0.0014
663 IMMUNE SYSTEM DISORDER 18 0.0014
664 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
665 APPETITE DISORDER 9 0.0014
666 MUSCULOSKELETAL CHEST PAIN 21 0.0014
667 NAUSEA 1072 0.0014
668 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
669 RESPIRATORY RATE INCREASED 12 0.0014
670 HAEMATEMESIS 34 0.0013
671 LUPUS-LIKE SYNDROME 12 0.0013
672 HYPERTENSION 278 0.0013
673 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
674 TACHYCARDIA 116 0.0013
675 SKIN PLAQUE 11 0.0013
676 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
677 UROSEPSIS 12 0.0013
678 OFF LABEL USE 1130 0.0013
679 THERAPY NON-RESPONDER 58 0.0013
680 EJECTION FRACTION DECREASED 20 0.0013
681 SPINAL PAIN 15 0.0013
682 INFECTION 184 0.0013
683 SINUS TACHYCARDIA 18 0.0013
684 CYTOMEGALOVIRUS INFECTION 21 0.0013
685 OXYGEN SATURATION DECREASED 71 0.0013
686 VENTRICULAR FIBRILLATION 14 0.0013
687 RENAL CYST 10 0.0013
688 DYSPNOEA 706 0.0012
689 DRUG INTOLERANCE 120 0.0012
690 SKIN LESION 34 0.0012
691 RASH PRURITIC 67 0.0012
692 TOXICITY TO VARIOUS AGENTS 207 0.0012
693 NEOPLASM 14 0.0012
694 HAEMATURIA 41 0.0012
695 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
696 RENAL DISORDER 55 0.0012
697 HEPATIC ENCEPHALOPATHY 11 0.0012
698 PRODUCT USE IN UNAPPROVED INDICATION 292 0.0012
699 APPENDICITIS 11 0.0012
700 CHOLECYSTITIS 14 0.0012
701 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 61 0.0012
702 HYPOTENSION 233 0.0012
703 ANGINA PECTORIS 33 0.0012
704 REBOUND EFFECT 13 0.0011
705 NODULE 15 0.0011
706 CARDIO-RESPIRATORY ARREST 47 0.0011
707 DIPLOPIA 29 0.0011
708 ORAL PAIN 25 0.0011
709 MENTAL STATUS CHANGES 31 0.0011
710 DYSGEUSIA 82 0.0011
711 TACHYPNOEA 15 0.0011
712 ACUTE HEPATIC FAILURE 15 0.0011
713 ASPIRATION 12 0.0011
714 MYOCLONUS 13 0.0011
715 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
716 TREATMENT FAILURE 90 0.0011
717 CEREBRAL DISORDER 8 0.0011
718 URINARY RETENTION 36 0.0011
719 RECTAL HAEMORRHAGE 46 0.0011
720 DYSARTHRIA 40 0.0011
721 PANCREATITIS 55 0.0010
722 DEVICE RELATED INFECTION 16 0.0010
723 PYELONEPHRITIS 9 0.0010
724 MYELODYSPLASTIC SYNDROME 15 0.0010
725 SINUS BRADYCARDIA 10 0.0010
726 DRUG INTERACTION 164 0.0010
727 URINE OUTPUT DECREASED 9 0.0010
728 DRUG TOXICITY 14 0.0010
729 SYNCOPE 101 0.0010
730 IMMUNODEFICIENCY 15 0.0010
731 THROMBOSIS 80 0.0010
732 FATIGUE 772 0.0010
733 OPTIC NEURITIS 9 0.0010
734 BLOOD POTASSIUM INCREASED 16 0.0010
735 OCULAR DISCOMFORT 11 0.0010
736 BONE PAIN 57 0.0010
737 ERYTHEMA 200 0.0010
738 ESCHERICHIA INFECTION 8 0.0010
739 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
740 LIVER FUNCTION TEST ABNORMAL 28 0.0010
741 LACRIMATION INCREASED 29 0.0010
742 CONDITION AGGRAVATED 291 0.0010
743 SHOCK 22 0.0010
744 CANDIDA INFECTION 16 0.0009
745 COUGH 264 0.0009
746 RASH ERYTHEMATOUS 45 0.0009
747 ANOREXIA 12 0.0009
748 CHROMATURIA 21 0.0009
749 DEATH 801 0.0009
750 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
751 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
752 CHRONIC KIDNEY DISEASE 70 0.0009
753 BACK INJURY 10 0.0009
754 EOSINOPHILIA 16 0.0009
755 CARDIAC ARREST 75 0.0009
756 PRODUCTIVE COUGH 43 0.0009
757 THIRST 16 0.0009
758 EYELID PTOSIS 9 0.0009
759 MITRAL VALVE INCOMPETENCE 10 0.0009
760 MOTOR DYSFUNCTION 9 0.0009
761 PRESCRIBED OVERDOSE 17 0.0009
762 SCAB 10 0.0009
763 HAEMORRHAGE 91 0.0009
764 DYSURIA 32 0.0009
765 MUSCLE ATROPHY 11 0.0009
766 TENDERNESS 9 0.0009
767 MUSCULOSKELETAL PAIN 45 0.0009
768 DIABETES MELLITUS 65 0.0009
769 ABDOMINAL PAIN 197 0.0008
770 COAGULOPATHY 14 0.0008
771 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
772 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
773 PULMONARY THROMBOSIS 9 0.0008
774 MUSCULAR WEAKNESS 93 0.0008
775 ULCER 13 0.0008
776 HYPERTENSIVE CRISIS 9 0.0008
777 HEPATIC STEATOSIS 15 0.0008
778 DYSPHONIA 47 0.0008
779 RESPIRATORY DISORDER 24 0.0008
780 DERMATITIS ALLERGIC 10 0.0008
781 INFLAMMATION 41 0.0008
782 LOWER RESPIRATORY TRACT INFECTION 36 0.0008
783 CHEST PAIN 146 0.0008
784 CONFUSIONAL STATE 127 0.0008
785 WEIGHT DECREASED 217 0.0008
786 PULMONARY HYPERTENSION 16 0.0008
787 BLOOD POTASSIUM DECREASED 23 0.0008
788 HYPERLIPIDAEMIA 9 0.0008
789 DRUG INEFFECTIVE 983 0.0007
790 JAUNDICE 20 0.0007
791 MUSCLE TIGHTNESS 12 0.0007
792 BLOOD URINE PRESENT 14 0.0007
793 UVEITIS 10 0.0007
794 NERVOUS SYSTEM DISORDER 23 0.0007
795 SKIN ULCER 19 0.0007
796 URINARY TRACT INFECTION 125 0.0007
797 SYSTEMIC LUPUS ERYTHEMATOSUS 26 0.0007
798 CORONARY ARTERY OCCLUSION 10 0.0007
799 STAPHYLOCOCCAL INFECTION 24 0.0007
800 THERAPEUTIC RESPONSE DECREASED 44 0.0007
801 SKIN FISSURES 14 0.0007
802 PULMONARY OEDEMA 32 0.0007
803 RENAL INJURY 21 0.0007
804 COVID-19 123 0.0007
805 ANGIOEDEMA 31 0.0007
806 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
807 PRESYNCOPE 17 0.0007
808 BACTERIAL INFECTION 13 0.0007
809 CORONARY ARTERY DISEASE 21 0.0007
810 TASTE DISORDER 14 0.0007
811 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
812 RASH PAPULAR 15 0.0007
813 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
814 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
815 DEAFNESS 17 0.0006
816 PHARYNGEAL OEDEMA 10 0.0006
817 VERTIGO 39 0.0006
818 PRODUCT USE ISSUE 120 0.0006
819 CEREBROVASCULAR ACCIDENT 108 0.0006
820 SEIZURE 73 0.0006
821 FLUSHING 64 0.0006
822 POST PROCEDURAL COMPLICATION 12 0.0006
823 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
824 HEPATIC ENZYME INCREASED 42 0.0006
825 CHEST DISCOMFORT 63 0.0006
826 ARRHYTHMIA 29 0.0006
827 CHOLELITHIASIS 20 0.0006
828 HERPES ZOSTER 35 0.0006
829 OSTEOPOROSIS 25 0.0006
830 BONE DISORDER 11 0.0006
831 FUNGAL INFECTION 20 0.0006
832 MYALGIA 102 0.0006
833 HAEMATOCHEZIA 33 0.0006
834 APHASIA 18 0.0006
835 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
836 BODY TEMPERATURE INCREASED 12 0.0006
837 DELUSION 9 0.0006
838 DRUG EFFECT INCOMPLETE 21 0.0006
839 NEURALGIA 14 0.0006
840 DEVICE OCCLUSION 8 0.0006
841 OROPHARYNGEAL PAIN 52 0.0006
842 HYPERSENSITIVITY 104 0.0006
843 ECZEMA 29 0.0006
844 ABDOMINAL PAIN LOWER 14 0.0006
845 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
846 DRUG LEVEL INCREASED 9 0.0005
847 BACK PAIN 125 0.0005
848 PARAESTHESIA 84 0.0005
849 MYOCARDIAL INFARCTION 93 0.0005
850 METABOLIC ACIDOSIS 17 0.0005
851 MALAISE 233 0.0005
852 INTESTINAL OBSTRUCTION 20 0.0005
853 PAIN IN JAW 15 0.0005
854 BLOOD PRESSURE DECREASED 35 0.0005
855 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
856 MUSCULOSKELETAL DISCOMFORT 9 0.0005
857 AGEUSIA 13 0.0005
858 PRURITUS 200 0.0005
859 RETCHING 11 0.0005
860 VIRAL INFECTION 17 0.0005
861 LABORATORY TEST ABNORMAL 15 0.0005
862 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
863 URINARY INCONTINENCE 15 0.0005
864 ALOPECIA 99 0.0005
865 UNRESPONSIVE TO STIMULI 13 0.0005
866 CEREBRAL HAEMORRHAGE 18 0.0005
867 HAEMATOMA 13 0.0005
868 SPINAL FRACTURE 10 0.0005
869 FLATULENCE 28 0.0005
870 SLEEP APNOEA SYNDROME 9 0.0005
871 BLINDNESS 19 0.0005
872 RESTLESSNESS 17 0.0005
873 DIZZINESS 231 0.0005
874 SKIN EXFOLIATION 39 0.0005
875 HAEMORRHOIDS 9 0.0005
876 PRODUCT PRESCRIBING ISSUE 10 0.0005
877 ABDOMINAL PAIN UPPER 94 0.0005
878 ADVERSE DRUG REACTION 41 0.0005
879 ADVERSE EVENT 42 0.0005
880 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
881 CHILLS 53 0.0005
882 BLOOD GLUCOSE ABNORMAL 8 0.0004
883 OCULAR HYPERAEMIA 20 0.0004
884 ARTHRITIS 33 0.0004
885 JOINT STIFFNESS 11 0.0004
886 HYPOACUSIS 18 0.0004
887 POOR QUALITY SLEEP 9 0.0004
888 TYPE 2 DIABETES MELLITUS 14 0.0004
889 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
890 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
891 BRONCHITIS 30 0.0004
892 WHEEZING 24 0.0004
893 DRY SKIN 54 0.0004
894 NEOPLASM MALIGNANT 27 0.0004
895 DISORIENTATION 16 0.0004
896 RESPIRATORY ARREST 11 0.0004
897 TINNITUS 18 0.0004
898 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
899 ABDOMINAL DISTENSION 40 0.0004
900 DRY MOUTH 31 0.0004
901 COLITIS ULCERATIVE 17 0.0004
902 COMA 18 0.0004
903 SOMNOLENCE 76 0.0004
904 BRADYCARDIA 20 0.0004
905 NECK PAIN 21 0.0004
906 FAECES DISCOLOURED 8 0.0004
907 PALLOR 10 0.0004
908 IMPAIRED HEALING 12 0.0004
909 RHINORRHOEA 23 0.0004
910 ARTHRALGIA 146 0.0004
911 ERECTILE DYSFUNCTION 9 0.0004
912 SKIN DISCOLOURATION 16 0.0003
913 BALANCE DISORDER 30 0.0003
914 DYSSTASIA 10 0.0003
915 PAIN 209 0.0003
916 BLISTER 19 0.0003
917 FLUID RETENTION 17 0.0003
918 LOCALISED INFECTION 8 0.0003
919 HYPOGLYCAEMIA 16 0.0003
920 ILL-DEFINED DISORDER 19 0.0003
921 HEADACHE 196 0.0003
922 LOSS OF CONSCIOUSNESS 40 0.0003
923 RHABDOMYOLYSIS 13 0.0003
924 MOVEMENT DISORDER 10 0.0003
925 PALPITATIONS 36 0.0003
926 SWELLING FACE 20 0.0003
927 INFLUENZA 34 0.0003
928 VISUAL IMPAIRMENT 36 0.0003
929 CONVULSION 16 0.0003
930 LETHARGY 16 0.0003
931 OSTEONECROSIS 9 0.0003
932 FALL 90 0.0003
933 LIP SWELLING 9 0.0003
934 RHEUMATOID ARTHRITIS 30 0.0003
935 HYPERHIDROSIS 34 0.0003
936 DISCOMFORT 16 0.0003
937 BLOOD GLUCOSE INCREASED 49 0.0003
938 FEMUR FRACTURE 8 0.0003
939 RASH MACULAR 9 0.0003
940 VISION BLURRED 35 0.0003
941 DYSPEPSIA 25 0.0003
942 MOBILITY DECREASED 18 0.0003
943 JOINT SWELLING 30 0.0002
944 SPEECH DISORDER 13 0.0002
945 DEPRESSED MOOD 13 0.0002
946 FEELING HOT 15 0.0002
947 PAIN IN EXTREMITY 70 0.0002
948 CARDIAC FAILURE CONGESTIVE 19 0.0002
949 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
950 BLOOD PRESSURE INCREASED 35 0.0002
951 HEART RATE DECREASED 8 0.0002
952 HOT FLUSH 17 0.0002
953 GAIT DISTURBANCE 43 0.0002
954 DISTURBANCE IN ATTENTION 12 0.0002
955 WEIGHT INCREASED 49 0.0002
956 NEPHROLITHIASIS 10 0.0002
957 INSOMNIA 58 0.0002
958 POLLAKIURIA 9 0.0002
959 URTICARIA 36 0.0002
960 ANXIETY 61 0.0002
961 HEART RATE INCREASED 21 0.0002
962 SKIN BURNING SENSATION 15 0.0002
963 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
964 VAGINAL HAEMORRHAGE 9 0.0002
965 DEPRESSION 47 0.0002
966 AGITATION 15 0.0002
967 TREATMENT NONCOMPLIANCE 11 0.0002
968 HYPOAESTHESIA 30 0.0002
969 PSORIASIS 24 0.0002
970 PERIPHERAL SWELLING 28 0.0002
971 ARTHROPATHY 10 0.0002
972 ACNE 13 0.0002
973 INFLUENZA LIKE ILLNESS 13 0.0002
974 SLEEP DISORDER 11 0.0002
975 NASOPHARYNGITIS 28 0.0002
976 CONTUSION 14 0.0001
977 CATARACT 8 0.0001
978 ABDOMINAL DISCOMFORT 22 0.0001
979 HOSPITALISATION 20 0.0001
980 OVERDOSE 26 0.0001
981 HALLUCINATION 9 0.0001
982 CARDIAC DISORDER 11 0.0001
983 TREMOR 19 0.0001
984 MUSCULOSKELETAL STIFFNESS 10 0.0001
985 SINUSITIS 11 0.0001
986 INTENTIONAL PRODUCT MISUSE 9 0.0001
987 INCORRECT DOSE ADMINISTERED 23 0.0001
988 NO ADVERSE EVENT 16 0.0001
989 FEELING ABNORMAL 21 0.0001
990 MEMORY IMPAIRMENT 12 0.0001
991 ASTHMA 9 0.0001
992 MUSCLE SPASMS 14 0.0001
993 EMOTIONAL DISTRESS 9 0.0001
994 PRODUCT DOSE OMISSION ISSUE 17 0.0001